An 11-year-old boy presented with 2 weeks of intermittent
headache, right orbital
pain, and constant
diplopia. Brain MRI showed dural thickening and enhancement of the right lateral cavernous sinus, right orbital apex, and tentorium. Initial cerebral spinal fluid analysis showed only mild
pleocytosis, and serum diagnostics were unrevealing. The working diagnosis was
Tolosa-Hunt syndrome. His
pain and
sixth nerve palsy resolved with
corticosteroids. Five months after initial presentation, he developed new
numbness of the right cheek, complete right
ophthalmoplegia, and weakness and
numbness of his right hand and leg, all of which were responsive to
steroids. Fifteen months later, he returned to the emergency department with 2 weeks of left-sided
headaches and acute
diplopia. On examination, he had a left cranial nerve 6
palsy. Dural biopsy showed diffuse mononuclear inflammatory cell reaction consisting mostly of lymphocytes with no signs of
granuloma formation, nor any epithelioid or giant cells. His
clinical course was consistent with an autoinflammatory condition of unknown etiology. Genetic testing with an immunodeficiency panel showed a risk allele in NOD2 (
nucleotide-binding oligomerization domain 2) c.3019dup (p.Leu1007Prof*2) that is associated with an increased risk for
Crohn disease. His clinical condition had similarities to central nervous system
sarcoidosis. Because of the similarities between our patient's clinical, imaging, and genetic findings and
neurosarcoidosis, he was switched to a more targeted
therapy-
infliximab. His condition has since been stable for nearly 2 years. In conclusion, genetic testing should be considered in patients with suspected occult autoimmunity.